10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2015 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2015 | Dec 31, 2014 | |
Assets | ||
Current Assets: | ||
Cash and cash equivalents | $ 5,001 | 4,063 |
Investments, primarily bank time deposits and U.S. treasury bills | 1,124 | 397 |
Trade receivables, less allowances of - 2015: $337; 2014: $310 | 3,418 | 3,586 |
Inventories: | ||
Finished products | 1,744 | 1,807 |
Work in process | 316 | 278 |
Materials | 539 | 558 |
Total inventories | 2,599 | 2,643 |
Other prepaid expenses and receivables | 1,908 | 1,975 |
Current assets held for disposition | 105 | 892 |
Total Current Assets | 14,155 | 13,556 |
Investments | 4,041 | 229 |
Property and Equipment, at Cost: | ||
Land | 432 | 457 |
Buildings | 2,769 | 2,968 |
Equipment | 8,254 | 8,480 |
Construction in progress | 928 | 727 |
Property and equipment, at cost | 12,383 | 12,632 |
Less: accumulated depreciation and amortization | 6,653 | 6,697 |
Net property and equipment | 5,730 | 5,935 |
Intangible assets, net of amortization | 5,562 | 6,198 |
Goodwill | 9,638 | 10,067 |
Deferred income taxes and other assets | 2,119 | 3,288 |
Non-current assets held for disposition | 2 | 1,934 |
Total Assets | 41,247 | 41,207 |
Liabilities and Shareholders' Investment | ||
Current Liabilities: | ||
Short-term borrowings | 3,127 | 4,382 |
Trade accounts payable | 1,081 | 1,064 |
Salaries, wages and commissions | 746 | 776 |
Other accrued liabilities | 3,043 | 2,878 |
Dividends payable | 383 | 362 |
Income taxes payable | 430 | 270 |
Current portion of long-term debt | 3 | 55 |
Current liabilities held for disposition | 373 | 680 |
Total Current Liabilities | 9,186 | 10,467 |
Long-term debt | 5,871 | 3,393 |
Post-employment Obligations, deferred income taxes and other long - term Liabilities | 4,864 | 5,600 |
Non-current liabilities held for disposition | 108 | |
Commitments and Contingencies | ||
Shareholders' Investment: | ||
Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2015: 1,702,017,390; 2014: 1,694,929,949 | 12,734 | 12,383 |
Common shares held in treasury, at cost - Shares: 2015: 229,352,338; 2014: 186,894,515 | (10,622) | (8,678) |
Earnings employed in the business | 25,757 | 22,874 |
Accumulated other comprehensive income (loss) | (6,658) | (5,053) |
Total Abbott Shareholders' Investment | 21,211 | 21,526 |
Noncontrolling Interests in Subsidiaries | 115 | 113 |
Total Shareholders' Investment | 21,326 | 21,639 |
Total Liabilities and Shareholders' Investment | 41,247 | 41,207 |
External Links | |
ABBOTT LABORATORIES (ABT) Fiscal Year 2015 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |